Molecular Characterisation of Colorectal Cancer Peritoneal Metastases
Recruiting · NCT05513716 · Observational (researchers observe without assigning treatment) · Lead sponsor: The Christie NHS Foundation Trust
View the official record on ClinicalTrials.gov →Interventions studied
Retrospective tissue sample analysis
What this trial is about
This project aims to characterise the tumour cell and tumour microenvironment of colorectal cancer peritoneal metastases, understand molecular changes leading to colorectal peritoneal metastasis, identify potential biomarkers and novel treatment strategies.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Eligibility criteria (as published)
Participants are eligible to be included in the study only if all of the following criteria apply:
1. Patients ≥ 18 years old who have been diagnosed with colorectal cancer and have colorectal peritoneal metastases,
2. have had cytoreductive surgery at the Christie
3. have availability of archival tumour tissue (paired CRC and CRPM)
Exclusion Criteria:
* None
Where it is running
1 location listed.
- Christie Hospital NHS Foundation Trust - Manchester, United Kingdom